An 2016 interview with Sijumon Kunjacha, PhD, of the Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School discusses his study of a dual-targeting strategy to specifically amplify damage in the tumor neoendothelium. The resulting tumor vascular disruption substantially improved the therapeutic outcome than targeting the cells alone
Create your
podcast in
minutes
It is Free